CordenPharma appointed Jean-Luc Herbeaux as CEO, effective October 1, 2026. Herbeaux previously led Hovione; outgoing CEO Michael Quirmbach moved to a board and senior-advisor role.
Oxford-based cell and gene therapy CDMO OXB named Joachim Kreuzburg an independent non-executive director, with the appointment scheduled to take effect November 23, 2026.
CDMO hiring and leadership moves include Bend Bioscience appointing Sandeep Patel as CFO and Pavlos Pavlidis as president, and Codis naming Steven Facer chief commercial officer.
FUJIFILM Biotechnologies received a 2026 CDMO Leadership Award for Most Innovative CDMO (Biologics), highlighting its ShunzymeX purification platform.
Industry executives reported improving CDMO order inflows in the second half of FY26, citing better biotech funding, normalized inventories, stronger outsourcing demand, and increased late-stage programs. Leaders cautioned that the recovery may take time to translate into growth.
Sources:
Changing Faces: Digital and supplier hires, September 2026
Changing Faces: Digital and supplier hires, August 2026
FUJIFILM Biotechnologies Named a 2026 CDMO ...
CDMO order inflows pick up in H2FY26 on funding recovery, outsourcing demand
CDMO 360 | Bi-Weekly News | 31/07/2026
CordenPharma Appoints Jean-Luc Herbeaux as Chief Executive Officer
Changing Faces: Digital and supplier hires, June and July ...
Supplier News: Neuland Labs, Cambrex, Esteve CDMO ...
Contract Development And Manufacturing Organizations ...
OXB Appoints Joachim Kreuzburg as Independent Non ...
Made Scientific, CordenPharma, WuXi XDC & More